1. Home
  2. LILAK vs INVA Comparison

LILAK vs INVA Comparison

Compare LILAK & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liberty Latin America Ltd. Class C

LILAK

Liberty Latin America Ltd. Class C

HOLD

Current Price

$8.68

Market Cap

1.7B

ML Signal

HOLD

Logo Innoviva Inc.

INVA

Innoviva Inc.

HOLD

Current Price

$20.62

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LILAK
INVA
Founded
2017
1996
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Cable & Other Pay Television Services
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
2017
2000

Fundamental Metrics

Financial Performance
Metric
LILAK
INVA
Price
$8.68
$20.62
Analyst Decision
Hold
Buy
Analyst Count
1
5
Target Price
$8.20
$32.80
AVG Volume (30 Days)
1.2M
549.5K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
7.55
816.67
EPS
N/A
1.25
Revenue
$4,442,200,000.00
$217,217,000.00
Revenue This Year
$1.37
$8.95
Revenue Next Year
N/A
$12.65
P/E Ratio
N/A
$16.90
Revenue Growth
N/A
62.63
52 Week Low
$4.75
$16.52
52 Week High
$9.13
$25.15

Technical Indicators

Market Signals
Indicator
LILAK
INVA
Relative Strength Index (RSI) 59.29 42.40
Support Level $7.38 $20.44
Resistance Level $8.93 $21.91
Average True Range (ATR) 0.25 0.38
MACD -0.01 0.02
Stochastic Oscillator 94.59 11.11

Price Performance

Historical Comparison
LILAK
INVA

About LILAK Liberty Latin America Ltd. Class C

Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.

About INVA Innoviva Inc.

Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.

Share on Social Networks: